POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...
WEST LAFAYETTE, Ind., July 12, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract ...
A recent analysis found that patients with a high genetic risk for rheumatoid arthritis (RA) do not face an increased risk for acute or late radiation-induced toxicities, suggesting no need to alter ...
Lurking within the genomes of nearly all species—including plants, fungi, and even humans—are genes that are passed from generation to generation with no clear benefit to the organism. Called "selfish ...
Regulatory Transition to Non-Animal Genotoxicity Assessment Tools and FDA Modernization Act 2.0 The FDA Modernization Act 2.0, signed in December 2022, struck mandatory animal-testing language from ...
Evaluation of the derivation of human colon adenocarcinoma from Lgr5 colon stem cells. Background: Genetic polymorphisms have been associated with toxicity from chemotherapeutic agents for colon ...
Transcriptome-based response predictor to identify potential responders among patients with negative standard markers for response to immune checkpoint blockers.
Please provide your email address to receive an email when new articles are posted on . Genetic testing can be accomplished for most patients with gastrointestinal cancer prior to starting ...
The application of pharmacogenetics in identifying single nucleotide polymorphisms (SNPs) in DNA sequences that cause clinically significant alterations in drug-metabolizing enzyme activities is ...
Gentronix, a British contract research organization that specializes in genetic toxicology, is officially off the market. Danish CRO Scantox, with its majority owner Impilo, bought Gentronix and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results